Immunovant, Inc.: Form 4, filed Oct 7, 2022
Filed with the SEC on Oct 7, 2022 and accepted by EDGAR at Oct 7, 2022, 16:32 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001140361-22-036652. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.